Boehringer Ingelheim Biopharmaceuticals GmbH

Boehringer-Ingelheim-Biopharmaceuticals-GmbH-1.png
Boehringer-Ingelheim-Biopharmaceuticals-GmbH-1.png

Description

Boehringer Ingelheim BioXcellence™ is one of the leading biopharmaceutical contract manufacturer — a reliable partner that accompanies customers throughout the life cycle of their products. We provide E2E biopharmaceutical manufacturing based on mammalian cell culture and microbial fermentation, streamlining your product's lifecycle.
We have extensive experience with a variety of different host cells, producing a broad range of molecules in accordance with cGMP manufacturing guidelines and covering all stages of development, including aseptic filling. Our focus is on creating value for our customers through robust processes, optimal preparation for launch, and global clinical and commercial supplies of high-quality biopharmaceuticals.
With over 40 years of biotechnology experience and a team of dedicated and highly trained employees, we have helped our customers bring more than 45 biopharmaceutical medicines to the market.
Our network of manufacturing facilities spans the globe, from Fremont, California in the United States to Biberach in Germany, Vienna in Austria, and Shanghai in China. With more than 440 kL for mammalian cell culture and 12 kL for microbial fermentation in fully licensed multiproduct facilities we are your right partner for high-quality global supplies of biopharmaceuticals to patients.
Let’s build a future together based on our history. We have capabilities to complement your expertise and are committed to turning your biologic innovation into commercial reality.

Type of Drugs Manufactured:

Biologics

CDMO Services offer:

Drug Substance Manufacturing (API);Drug Product Formulation (FDF);Aseptic Fill Finish

No. of Manufacturing Facilities:

6-10

Facilities Locations:

Europe;North America;China

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);ISO;GMP;PMDA (Japan);NMPA (China);Health Canada;ANVISA (Brazil)

Manufacturing Technologies:

Liquids;Lyophilized amps/vials

Current Capacity:

Global mammalian manufacturing capacity: ~ 430,000 Liters
Microbial manufacturing capacity: > 12,000 Liters

 

Capabilities

Contact Information

Phone
Address
Boehringer Ingelheim Biopharmaceuticals GmbH, Binger Strasse 173, 55216, Ingelheim, Germany

The PharmaSource Newsletter

Register today to our free email newsletter for the latest insights into BioPharma outsourcing.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.